Clinical trial
Acamprosate Initiated During Alcohol Detoxification
NCT00360594 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00360594 |
|---|---|
| Title | Acamprosate Initiated During Alcohol Detoxification |
| Official title | Initiating Acamprosate Within Versus Post-detoxification in the Rehabilitative Treatment of Alcohol Dependence. |
| Lead sponsor | Forest Laboratories, Industry |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcohol Use Disorder |
| Intervention type | Drug |
| Interventions | Acamprosate, Placebo |
| Enrollment | 40 |
| Start date | Oct 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Aug 4, 2006 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: